These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9146972)

  • 1. Involvement of complement components in renal disease.
    Johnson RJ
    Curr Opin Nephrol Hypertens; 1997 Mar; 6(2):120-7. PubMed ID: 9146972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased susceptibility to erythrocyte C5b-9 deposition and complement-mediated lysis in chronic renal failure.
    Himmelfarb J; McMonagle E; Holbrook D; Hakim R
    Kidney Int; 1999 Feb; 55(2):659-66. PubMed ID: 9987090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
    Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
    Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement and renal disease.
    Trouw LA; Seelen MA; Daha MR
    Mol Immunol; 2003 Sep; 40(2-4):125-34. PubMed ID: 12914818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complement system: pathophysiology and clinical relevance.
    Speth C; Würzner R; Stoiber H; Dierich MP
    Wien Klin Wochenschr; 1999 May; 111(10):378-91. PubMed ID: 10413831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecules Great and Small: The Complement System.
    Mathern DR; Heeger PS
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1636-50. PubMed ID: 25568220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement and autoimmune glomerular diseases.
    Quigg RJ
    Curr Dir Autoimmun; 2004; 7():165-80. PubMed ID: 14719380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic inhibition of the complement system. Y2K update.
    Asghar SS; Pasch MC
    Front Biosci; 2000 Sep; 5():E63-81. PubMed ID: 10966868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is complement a target for therapy in renal disease?
    Mathieson PW
    Kidney Int; 1998 Nov; 54(5):1429-36. PubMed ID: 9844118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival.
    Candinas D; Lesnikoski BA; Robson SC; Miyatake T; Scesney SM; Marsh HC; Ryan US; Dalmasso AP; Hancock WW; Bach FH
    Transplantation; 1996 Aug; 62(3):336-42. PubMed ID: 8779679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement Activation in Progression of Chronic Kidney Disease.
    Chen SF; Chen M
    Adv Exp Med Biol; 2019; 1165():423-441. PubMed ID: 31399977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies directed against human C5 and C8 block complement-mediated damage of xenogeneic cells and organs.
    Rollins SA; Matis LA; Springhorn JP; Setter E; Wolff DW
    Transplantation; 1995 Dec; 60(11):1284-92. PubMed ID: 8525523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of complement in renal tubular damage.
    Khan TN; Sinniah R
    Histopathology; 1995 Apr; 26(4):351-6. PubMed ID: 7607624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury.
    Mulligan MS; Yeh CG; Rudolph AR; Ward PA
    J Immunol; 1992 Mar; 148(5):1479-85. PubMed ID: 1311349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.
    De Vries B; Matthijsen RA; Wolfs TG; Van Bijnen AA; Heeringa P; Buurman WA
    Transplantation; 2003 Feb; 75(3):375-82. PubMed ID: 12589162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The many effects of complement C3- and C5-binding proteins in renal injury.
    Puri TS; Quigg RJ
    Semin Nephrol; 2007 May; 27(3):321-37. PubMed ID: 17533009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models for complement deficiencies.
    Frank MM
    J Clin Immunol; 1995 Nov; 15(6 Suppl):113S-121S. PubMed ID: 8613484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9.
    Nangaku M; Alpers CE; Pippin J; Shankland SJ; Kurokawa K; Adler S; Johnson RJ; Couser WG
    Kidney Int; 1997 Dec; 52(6):1570-8. PubMed ID: 9407502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Human CD55 and CD59 or Treatment with Human CD55 Protects against Renal Ischemia-Reperfusion Injury in Mice.
    Bongoni AK; Lu B; Salvaris EJ; Roberts V; Fang D; McRae JL; Fisicaro N; Dwyer KM; Cowan PJ
    J Immunol; 2017 Jun; 198(12):4837-4845. PubMed ID: 28500075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel roles of complement in renal diseases and their therapeutic consequences.
    Wada T; Nangaku M
    Kidney Int; 2013 Sep; 84(3):441-50. PubMed ID: 23615508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.